Attempting to reap these benefits without the safety concerns has led to the development of micropulse (MP) TSCPC, which differs from CW-TSCPC in that the energy to the ciliary body is delivered ...

How Brian Emerick and Micropulse shed customers in an effort to focus on one industry and become an expert — and an incubator. COLUMBIA CITY, Indiana — Brian Emerick wanted to be a farmer. This was ...

However, I have become increasingly comfortable using MicroPulse (Iridex) transscleral cyclophotocoagulation (MP-TSCPC) in earlier-stage glaucoma and in patients with good vision, including ...

May 4, 2017 /PRNewswire/ -- IRIDEX Corporation (Nasdaq: IRIX) today announced the presentation of data demonstrating the safety and efficacy of its proprietary MicroPulse® technology for treating ...

When Micropulse was founded more than 35 years ago just outside Columbia City in northeast Indiana, the new contract manufacturer’s mission was simple: find customers. It didn’t matter if ...

The aim of this study was to investigate the safety and efficacy of using MicroPulse laser trabeculoplasty (MLT), first developed by IRIDEX (Mountain View, California), in the treatment of open ...

This study highlights the sustained safety and efficacy of MicroPulse Transscleral Laser Therapy (TLT) (also referred to as Transscleral Cyclophotocoagulation) in managing both primary and ...

The study, titled "MicroPulse Transscleral Laser Therapy: A Prospective UK Study," is set to expand Iridex’s global clinical portfolio, through its commitment to funding essential components of ...